(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine
-
(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine
structure -
-
CAS No:
300543-56-0
-
Formula:
C17H19ClN2
-
Chemical Name:
(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine
-
Synonyms:
Piperazine,1-[(R)-(4-chlorophenyl)phenylmethyl]-;1-[(R)-(4-Chlorophenyl)phenylmethyl]piperazine;(R)-1-(p-Chlorobenzhydryl)piperazine;(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine;N-[(R)-α-(4-Chlorophenylbenzyl]piperazine;1-[(R)-α-(4-Chlorophenylbenzyl]piperazine;1-[(R)-(4-Chlorophenyl)-phenylmethyl]piperazine;(R)-1-((4-Chlorophenyl)(phenyl)methyl)piperazine;130018-88-1
- Categories:
-
CAS No:
(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine Basic Attributes
286.8
286.80
1312995-182-4
890A9G29PG
2933599090
Characteristics
15.3
3.4
White Solid
1.2±0.1 g/cm3
409.1°C at 760 mmHg
193.3±26.5 °C
1.592
soluble in chloroform, methanol, and dichloromethane. Slightly soluble in water.
6.66E-07mmHg at 25°C
Safety Information
NONH for all modes of transport
|Warning|H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P391, P403+P233, P405, and P501|Aggregated GHS information provided by 4 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine Use and Manufacturing
40.0 g of 1-[(R)-(4-chlorophenyl) (phenyl) methyl] piperazine, 14.1 g of sodium hydrogen carbonateAnd a mixture of 78.1 g of N-methyl-2-pyrrolidoneHeat to 120 C, ethyl (2-chloroethoxy) acetateAfter 27.9 g was dropped over 30 minutes, the mixture was stirred for 6 hours.After cooling the obtained suspension to room temperature, 200 g of waterAnd toluene 69gAnd the mixture was separated.120 g of water is added to the obtained organic layer, and liquid separation is performed again to obtain the formula (6).; 32 g of water was added to a toluene solution of the compound (6) obtained in Reference Example 1, and a solution of 7.0 g of lithium hydroxide monohydrate dissolved in 44 g of water was added dropwise at room temperature. It stirred until it became 0.2% or less. Liquid separation was carried out after the obtained solution, 8 g of N-methyl-2-pyrrolidone for washing, 139 g of toluene and 25 g of acetone were mixed. To the separated aqueous layer were added 139 g of toluene and 13 g of acetone to carry out liquid separation again. Further, 139 g of toluene and 9 g of acetone were added to the separated aqueous layer, and liquid separation was performed again. 35 g of toluene and 193 g of methyl ethyl ketone were added to the obtained aqueous layer, and 29.1 g of 35% hydrochloric acid was dropped to adjust the pH to 2.4, and the solution was heated to 45 C. to separate. After 35 g of toluene was added to the obtained organic layer, concentration was performed until the remaining amount became 95 g. Furthermore, 97 g of methyl ethyl ketone and 35 g of toluene were added and concentrated until the remaining amount reached 99 g, and further 24 g of methyl ethyl ketone and 9 g of toluene were added and concentrated until the remaining amount became 101 g. After adding methyl ethyl ketone 64g and acetone 411g at room temperature and dropping 7.3g of 35% hydrochloric acid, 0.04 g of levocetirizine dihydrochloride was added.Subsequently, 316 g of acetone was dropped, and after stirring for 1.5 hours, 6.9 g of 35% hydrochloric acid was dropped. After filtering the obtained suspension, the obtained solid was washed with 95 g of acetone. The obtained crystals were dried under reduced pressure at 40 C. to obtain 54.6 g of levocetirizine dihydrochloride. The purity was 99.8% or more
Intermediate in the production of (R)-Cetirizine (C281106).
Computed Properties
Molecular Weight:286.8
XLogP3:3.4
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:3
Exact Mass:286.1236763
Monoisotopic Mass:286.1236763
Topological Polar Surface Area:15.3
Heavy Atom Count:20
Complexity:277
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of (-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of Active Pharm Ingredients,Chemical Catalyst,Pharmaceutical Intermediates,Flavors and Fragrances,Agrochemicals,Chemical Pesticides,Organic Intermediates,OLED IntermediatesInquiryCAS No.: 300543-56-0Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
(2E)-3-(1-METHYL-1H-PYRROL-2-YL)ACRYLIC ACID
51485-76-8
-
Benadryl N-oxide hydrochloride
13168-00-8
-
6-CHLORO-3-IODO-IMIDAZO[1,2-A]PYRIDINE
885275-59-2
-
(2-Bromophenyl)diphenylphosphine Formula
62336-24-7
-
1-Morpholinocyclopentene Formula
936-52-7
-
4-[2-(Boc-amino)ethoxy]-benzoic acid Formula
168892-66-8
-
3-amino-5-bromopyridine-2-carboxylic acid Structure
870997-85-6
-
2-Amino-6-methylpyridine Structure
1824-81-3
-
What is 3-Bromo-2-methylthiophene
30319-05-2
-
What is THIOPHEN-2-YLMETHYL-PHOSPHONICACIDDIETHYLESTER
2026-42-8
(-)-1-[(4-Chlorophenyl)phenylmethyl]piperazine
SDSRequest for Quotation